We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$240B
AUM Growth
+$11.1B
Cap. Flow
-$5.81B
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.58%
Holding
2,654
New
464
Increased
1,324
Reduced
690
Closed
110

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$868M
2
AMZN icon
Amazon
AMZN
+$726M
3
UNH icon
UnitedHealth
UNH
+$571M
4
RIVN icon
Rivian
RIVN
+$559M
5
TJX icon
TJX Companies
TJX
+$441M

Sector Composition

Rank Sector Weight
1 Technology 32.51%
2 Healthcare 18.41%
3 Consumer Discretionary 11.39%
4 Financials 9.7%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUMA icon
2501
Humacyte
HUMA
$168M
$98K ﹤0.01%
+13,513
New +$134K
CTLP
2502
DELISTED
Cantaloupe
CTLP
$96K ﹤0.01%
+10,850
New +$108K
WKHS icon
2503
Workhorse Group
WKHS
$33.4M
$96K ﹤0.01%
7
+3
+75% +$54.5K
MMAT
2504
DELISTED
Meta Materials Inc. Common Stock
MMAT
$96K ﹤0.01%
+390
New +$161K
AMRX icon
2505
Amneal Pharmaceuticals
AMRX
$6.1B
$94K ﹤0.01%
+19,621
New +$97.8K
MAPS
2506
DELISTED
WM TECHNOLOGY INC A
MAPS
$92K ﹤0.01%
+15,471
New +$152K
HLX icon
2507
Helix Energy Solutions
HLX
$1.34B
$91K ﹤0.01%
29,068
+14,616
+101% +$53.9K
OCUL icon
2508
Ocular Therapeutix
OCUL
$1.83B
$91K ﹤0.01%
+13,073
New +$102K
RIGL icon
2509
Rigel Pharmaceuticals
RIGL
$723M
$91K ﹤0.01%
3,433
+1,727
+101% +$52.1K
IDEX
2510
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$91K ﹤0.01%
616
+311
+102% +$66.4K
RKLY
2511
DELISTED
Rockley Photonics Holdings Limited
RKLY
$91K ﹤0.01%
+20,985
New +$132K
MDXG icon
2512
MiMedx Group
MDXG
$630M
$89K ﹤0.01%
+14,712
New +$102K
VLDR
2513
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$89K ﹤0.01%
+19,148
New +$112K
INSG icon
2514
Inseego
INSG
$104M
$88K ﹤0.01%
+1,516
New +$98.5K
EGIO
2515
DELISTED
Edgio, Inc. Common Stock
EGIO
$86K ﹤0.01%
629
+316
+101% +$37.6K
KPTI icon
2516
Karyopharm Therapeutics
KPTI
$155M
$78K ﹤0.01%
+811
New +$80.8K
WTTR icon
2517
Select Water Solutions
WTTR
$2.22B
$78K ﹤0.01%
+12,522
New +$77.9K
VBIV
2518
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$78K ﹤0.01%
1,111
+553
+99% +$46.6K
VERU icon
2519
Veru
VERU
$35.5M
$75K ﹤0.01%
+1,274
New +$97.5K
MRSN
2520
DELISTED
Mersana Therapeutics
MRSN
$70K ﹤0.01%
+448
New +$87.2K
PGEN icon
2521
Precigen
PGEN
$1.94B
$69K ﹤0.01%
+18,572
New +$79.9K
AMWL icon
2522
American Well
AMWL
$180M
$68K ﹤0.01%
+559
New +$85.2K
MUX icon
2523
McEwen Inc
MUX
$1B
$68K ﹤0.01%
7,681
+3,823
+99% +$39.8K
AKBA icon
2524
Akebia Therapeutics
AKBA
$338M
$67K ﹤0.01%
29,775
+15,030
+102% +$41K
ALTO icon
2525
Alto Ingredients
ALTO
$338M
$67K ﹤0.01%
+13,957
New +$73.3K

Similar funds

Janus Henderson Group's Q4 2021 Portfolio in Review

As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
  • Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
  • Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
  • Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
  • Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
  • Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
  • Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.

Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.